# Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-24-293
- **Status:** posted
- **Opens:** October 1, 2024
- **Closes:** August 18, 2027
- **CFDA:** 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/356610

## Description

No description provided.